The UK's NHS and pharma: from schism to symbiosis

The Lancet

Volumn 373, Issue 9662, 2009, Pages 435-436

  Horton, Richard ^a  

^a THE LANCET   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DRUG INDUSTRY; HEALTH CARE MANAGEMENT; HEALTH CARE SYSTEM; MEDICAL PERSONNEL; NATIONAL HEALTH SERVICE; PRIORITY JOURNAL; UNITED KINGDOM;

EID: 59249102485     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(09)60148-3     Document Type: Note

References (6)

1. House of Commons Health Select Committee. The influence of the pharmaceutical industry (2005), Stationery Office, London
2. Royal College of Physicians. Innovating for health: patients, physicians, the pharmaceutical industry, and the NHS. Report of a working party (2009), Royal College of Physicians, London
3. Richards M. Improving access to medicines for NHS patients (2008), Stationery Office, London
4. Illing J., Morrow G., Kergon C., et al. How prepared are medical graduates to begin practice? A comparison of three diverse UK medical schools. Final summary and conclusions for the GMC Education Committee. http://www.gmc-uk.org/about/research/REPORT%20-preparedness%20of%20medical%20grads.pdf (accessed Feb 1, 2009).
5. Heaton A., Webb D., and Maxwell S.R.J. Undergraduate preparation for prescribing: the views of 2413 UK medical students and recent graduates. Br J Clin Pharmacol 66 (2008) 128-134
6. Griffin G.E., Brown M., Gilmore I., et al. UK research trials are on verge of extinction. The Times (Jan 14, 2009) 27